Israel imports patented antivirals for treating COVID-19

Israel has approved generic versions of an HIV antiviral owned by AbbVie for use in treating coronavirus, despite the company still holding patent protection and doubts over its effectiveness.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Israel targets Teva over MS drug royalties

12 May 2022 The state of Israel has sued Teva Pharmaceuticals for $100 million over alleged unpaid royalties relating to its multiple sclerosis drug, Copaxone.

Big Pharma

EU should buy patent rights for COVID-19 tests, says Greece

7 April 2020 Greece has reportedly suggested that EU member states should jointly buy patent rights for COVID-19 tests and vaccines to ensure rapid distribution across the EU.

Americas

Costa Rica asks WHO to create voluntary COVID-19 IP pool

26 March 2020 The Costa Rican government has asked the World Health Organization to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.

More on this story

Big Pharma

Israel targets Teva over MS drug royalties

12 May 2022 The state of Israel has sued Teva Pharmaceuticals for $100 million over alleged unpaid royalties relating to its multiple sclerosis drug, Copaxone.

Big Pharma

EU should buy patent rights for COVID-19 tests, says Greece

7 April 2020 Greece has reportedly suggested that EU member states should jointly buy patent rights for COVID-19 tests and vaccines to ensure rapid distribution across the EU.

Americas

Costa Rica asks WHO to create voluntary COVID-19 IP pool

More on this story

Big Pharma

Israel targets Teva over MS drug royalties

12 May 2022 The state of Israel has sued Teva Pharmaceuticals for $100 million over alleged unpaid royalties relating to its multiple sclerosis drug, Copaxone.

Big Pharma

EU should buy patent rights for COVID-19 tests, says Greece

7 April 2020 Greece has reportedly suggested that EU member states should jointly buy patent rights for COVID-19 tests and vaccines to ensure rapid distribution across the EU.

Americas

Costa Rica asks WHO to create voluntary COVID-19 IP pool